Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 548w is an RNA gene belonging to the miR-548 family, a large and poorly conserved group of primate-specific microRNAs derived from transposable elements. Like other miRNAs, MIR548W is transcribed by RNA polymerase II, processed by Drosha and Dicer, and incorporated into the RNA-induced silencing complex (RISC) to regulate mRNA stability and translation primarily via imperfect base pairing. Functional enrichment analyses indicate miR-548 family members (by extension, likely including MIR548W) regulate genes involved in cellular adhesion, cytoskeleton remodeling, cell cycle control, signaling pathways (MAPK, Wnt, p53), and pathways implicated in cancer and other diseases. There is limited direct functional or mechanistic data for MIR548W itself, and at present it is not considered a direct therapeutic target or druggable entity, although miRNA-based therapeutics are a growing area of research.
N/A for drugs targeting MIR548W (no approved drugs or known small molecules directly targeting this miRNA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 548w (MIR548W).